All News about Neogenomics Inc
NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021
February 23, 2022
From NeoGenomics, Inc.
Via AccessWire
Exposures
COVID-19
From NeoGenomics, Inc.
Via AccessWire
From NeoGenomics, Inc.
Via AccessWire
NASDAQ: NEO Shareholder Notice: Investigation over Potential Wrongdoing at NeoGenomics, Inc.
November 29, 2021
Via SBWire
Exposures
COVID-19
NASDAQ:NEO Investor Notice: Investigation over Possible Securities Laws Violations by NeoGenomics, Inc.
November 10, 2021
Via SBWire
Exposures
COVID-19
NeoGenomics Appoints Dave Daly to Its Board of Directors
November 10, 2021
From NeoGenomics, Inc.
Via AccessWire
Topics
Regulatory Compliance
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|